Hanesbrands Inc (HBI) Fundamental Analysis & Valuation

NYSE:HBI • US4103451021

Current stock price

6.47 USD
-0.12 (-1.82%)
At close:
6.65 USD
+0.18 (+2.78%)
Pre-Market:

This HBI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. HBI Profitability Analysis

1.1 Basic Checks

  • HBI had positive earnings in the past year.
  • HBI had a positive operating cash flow in the past year.
  • In the past 5 years HBI reported 4 times negative net income.
  • HBI had a positive operating cash flow in 4 of the past 5 years.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

  • HBI has a Return On Assets of 7.71%. This is amongst the best in the industry. HBI outperforms 84.78% of its industry peers.
  • HBI has a better Return On Equity (73.92%) than 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.06%, HBI is in the better half of the industry, outperforming 76.09% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HBI is in line with the industry average of 9.53%.
  • The 3 year average ROIC (9.25%) for HBI is below the current ROIC(12.06%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.71%
ROE 73.92%
ROIC 12.06%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.59%, HBI belongs to the top of the industry, outperforming 89.13% of the companies in the same industry.
  • With an excellent Operating Margin value of 13.46%, HBI belongs to the best of the industry, outperforming 84.78% of the companies in the same industry.
  • HBI's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 41.93%, HBI is doing worse than 63.04% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HBI has remained more or less at the same level.
Industry RankSector Rank
OM 13.46%
PM (TTM) 9.59%
GM 41.93%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HBI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HBI is creating some value.
  • Compared to 1 year ago, HBI has more shares outstanding
  • HBI has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HBI is higher compared to a year ago.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 1.89 indicates that HBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HBI's Altman-Z score of 1.89 is on the low side compared to the rest of the industry. HBI is outperformed by 76.09% of its industry peers.
  • A Debt/Equity ratio of 4.94 is on the high side and indicates that HBI has dependencies on debt financing.
  • HBI's Debt to Equity ratio of 4.94 is on the low side compared to the rest of the industry. HBI is outperformed by 89.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.94
Debt/FCF N/A
Altman-Z 1.89
ROIC/WACC1.11
WACC10.82%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • HBI has a Current Ratio of 1.51. This is a normal value and indicates that HBI is financially healthy and should not expect problems in meeting its short term obligations.
  • HBI has a worse Current ratio (1.51) than 73.91% of its industry peers.
  • HBI has a Quick Ratio of 1.51. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.71, HBI is not doing good in the industry: 84.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.71
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HBI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 103.23% over the past year.
  • HBI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.96% yearly.
  • HBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.16%.
  • HBI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.40% yearly.
EPS 1Y (TTM)103.23%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%0%
Revenue 1Y (TTM)-14.16%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-4.85%

3.2 Future

  • HBI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.79% yearly.
  • HBI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.46% yearly.
EPS Next Y46.56%
EPS Next 2Y23.88%
EPS Next 3Y20.18%
EPS Next 5Y13.79%
Revenue Next Year-2.25%
Revenue Next 2Y-1.78%
Revenue Next 3Y-0.63%
Revenue Next 5Y0.46%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. HBI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.27, the valuation of HBI can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of HBI indicates a rather cheap valuation: HBI is cheaper than 80.43% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.95. HBI is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 9.37, which indicates a very decent valuation of HBI.
  • Based on the Price/Forward Earnings ratio, HBI is valued cheaper than 91.30% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HBI to the average of the S&P500 Index (38.68), we can say HBI is valued rather cheaply.
Industry RankSector Rank
PE 10.27
Fwd PE 9.37
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 69.57% of the companies in the same industry are more expensive than HBI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.65
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of HBI may justify a higher PE ratio.
  • A more expensive valuation may be justified as HBI's earnings are expected to grow with 20.18% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y23.88%
EPS Next 3Y20.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HBI Dividend Analysis

5.1 Amount

  • HBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HBI Fundamentals: All Metrics, Ratios and Statistics

Hanesbrands Inc

NYSE:HBI (11/28/2025, 7:36:26 PM)

Premarket: 6.65 +0.18 (+2.78%)

6.47

-0.12 (-1.82%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-06
Earnings (Next)02-11
Inst Owners88.94%
Inst Owner Change-0.01%
Ins Owners0.65%
Ins Owner Change-84.82%
Market Cap2.29B
Revenue(TTM)3.44B
Net Income(TTM)330.01M
Analysts71.11
Price Target5.88 (-9.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.76%
Min EPS beat(2)-7.98%
Max EPS beat(2)33.5%
EPS beat(4)3
Avg EPS beat(4)65.2%
Min EPS beat(4)-7.98%
Max EPS beat(4)217.92%
EPS beat(8)6
Avg EPS beat(8)43.09%
EPS beat(12)8
Avg EPS beat(12)33.28%
EPS beat(16)10
Avg EPS beat(16)25.82%
Revenue beat(2)1
Avg Revenue beat(2)-0.13%
Min Revenue beat(2)-1.45%
Max Revenue beat(2)1.19%
Revenue beat(4)2
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-6.58%
Revenue beat(12)3
Avg Revenue beat(12)-4.77%
Revenue beat(16)4
Avg Revenue beat(16)-4.44%
PT rev (1m)-4.57%
PT rev (3m)-1.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)-1.48%
EPS NY rev (3m)-1.48%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.27
Fwd PE 9.37
P/S 0.67
P/FCF N/A
P/OCF 98.84
P/B 5.13
P/tB N/A
EV/EBITDA 8.65
EPS(TTM)0.63
EY9.74%
EPS(NY)0.69
Fwd EY10.67%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.07
OCFY1.01%
SpS9.72
BVpS1.26
TBVpS-3.14
PEG (NY)0.22
PEG (5Y)N/A
Graham Number4.22924 (-34.63%)
Profitability
Industry RankSector Rank
ROA 7.71%
ROE 73.92%
ROCE 15.27%
ROIC 12.06%
ROICexc 13%
ROICexgc 29.09%
OM 13.46%
PM (TTM) 9.59%
GM 41.93%
FCFM N/A
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexgc growth 3Y-1.22%
ROICexgc growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 4.94
Debt/FCF N/A
Debt/EBITDA 4.33
Cap/Depr 66.65%
Cap/Sales 0.91%
Interest Coverage 250
Cash Conversion 4.54%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.71
Altman-Z 1.89
F-Score7
WACC10.82%
ROIC/WACC1.11
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.23%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%0%
EPS Next Y46.56%
EPS Next 2Y23.88%
EPS Next 3Y20.18%
EPS Next 5Y13.79%
Revenue 1Y (TTM)-14.16%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-4.85%
Revenue Next Year-2.25%
Revenue Next 2Y-1.78%
Revenue Next 3Y-0.63%
Revenue Next 5Y0.46%
EBIT growth 1Y12.1%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year36.32%
EBIT Next 3Y12.11%
EBIT Next 5Y8.42%
FCF growth 1Y-102.39%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y-94.49%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%

Hanesbrands Inc / HBI Fundamental Analysis FAQ

What is the fundamental rating for HBI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HBI.


What is the valuation status for HBI stock?

ChartMill assigns a valuation rating of 7 / 10 to Hanesbrands Inc (HBI). This can be considered as Undervalued.


Can you provide the profitability details for Hanesbrands Inc?

Hanesbrands Inc (HBI) has a profitability rating of 6 / 10.


What is the financial health of Hanesbrands Inc (HBI) stock?

The financial health rating of Hanesbrands Inc (HBI) is 2 / 10.


Can you provide the dividend sustainability for HBI stock?

The dividend rating of Hanesbrands Inc (HBI) is 0 / 10 and the dividend payout ratio is 0%.